Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

FOSAMPRENAVIR vs FOSCARNET: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

FOSAMPRENAVIR vs FOSCARNET: Safety Overview

Metric FOSAMPRENAVIR FOSCARNET
Total FAERS Reports 460 2,057
Deaths Reported 31 605
Death Rate 6.7% 29.4%
Hospitalizations 91 608
Average Patient Age 45.3 yrs 41.8 yrs
% Female Patients 27.9% 40.6%
FDA Approval Date Apr 15, 2016 Apr 21, 2021
Manufacturer Sun Pharmaceutical Industries, Inc. Hikma Pharmaceuticals USA Inc.
Route ORAL INTRAVENOUS
Marketing Status Discontinued Prescription